Attitudes Toward and Preferences for Routes of Delivery of HIV Pre-exposure Prophylaxis Among Young Transgender Men and Transmasculine People.

Jessica A Kahn, Tanya L Kowalczyk Mullins
{"title":"Attitudes Toward and Preferences for Routes of Delivery of HIV Pre-exposure Prophylaxis Among Young Transgender Men and Transmasculine People.","authors":"Jessica A Kahn, Tanya L Kowalczyk Mullins","doi":"10.1016/j.jadohealth.2025.05.029","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Because delivery route may impact interest in human immunodeficiency virus pre-exposure prophylaxis (PrEP), we explored the attitudes toward and preferences of young transgender men and transmasculine youth (TG men) for PrEP delivery methods that are currently available and in development.</p><p><strong>Methods: </strong>Fifteen TG men aged 15-24 years were recruited from a Midwestern US youth-serving gender clinic. Participants completed theory-guided individual interviews assessing demographics, risk behaviors, attitudes toward and preferences for PrEP delivery routes, and experiences with hormones for vaginal bleeding management. Transcripts were analyzed using content analysis.</p><p><strong>Results: </strong>Mean age was 17.7 years (standard deviation 1.4); 12 identified as White, two biracial, and 1 Black; and 13 were sexually experienced. Oral pill benefits included ease of use, no planning around sex; barriers included adherence challenges, difficulty swallowing pills. Injection benefits included long-acting, ease of adherence; barriers included delivery as injection, discomfort with gluteal injection. Vaginal ring benefits included ease of use, long-acting; barriers included discomfort with vaginal objects, exacerbation of gender dysphoria. Topical benefits included as-needed use, ease of use; barriers included dislike of formulation, discomfort using vaginal/rectal products. Implant benefits included long-acting, ease of use; barriers included placement procedure, concerns about breakage/migration. Four of five participants who had experience with injection, implant, or intrauterine device for bleeding management reported preference for a PrEP implant. Six of nine participants who had experience with contraceptive pills reported preference for a PrEP pill.</p><p><strong>Discussion: </strong>PrEP uptake may be improved through clinicians' eliciting and addressing barriers to PrEP delivery routes identified by young TG men.</p>","PeriodicalId":520803,"journal":{"name":"The Journal of adolescent health : official publication of the Society for Adolescent Medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of adolescent health : official publication of the Society for Adolescent Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jadohealth.2025.05.029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Because delivery route may impact interest in human immunodeficiency virus pre-exposure prophylaxis (PrEP), we explored the attitudes toward and preferences of young transgender men and transmasculine youth (TG men) for PrEP delivery methods that are currently available and in development.

Methods: Fifteen TG men aged 15-24 years were recruited from a Midwestern US youth-serving gender clinic. Participants completed theory-guided individual interviews assessing demographics, risk behaviors, attitudes toward and preferences for PrEP delivery routes, and experiences with hormones for vaginal bleeding management. Transcripts were analyzed using content analysis.

Results: Mean age was 17.7 years (standard deviation 1.4); 12 identified as White, two biracial, and 1 Black; and 13 were sexually experienced. Oral pill benefits included ease of use, no planning around sex; barriers included adherence challenges, difficulty swallowing pills. Injection benefits included long-acting, ease of adherence; barriers included delivery as injection, discomfort with gluteal injection. Vaginal ring benefits included ease of use, long-acting; barriers included discomfort with vaginal objects, exacerbation of gender dysphoria. Topical benefits included as-needed use, ease of use; barriers included dislike of formulation, discomfort using vaginal/rectal products. Implant benefits included long-acting, ease of use; barriers included placement procedure, concerns about breakage/migration. Four of five participants who had experience with injection, implant, or intrauterine device for bleeding management reported preference for a PrEP implant. Six of nine participants who had experience with contraceptive pills reported preference for a PrEP pill.

Discussion: PrEP uptake may be improved through clinicians' eliciting and addressing barriers to PrEP delivery routes identified by young TG men.

年轻变性男性和跨性别人群对HIV暴露前预防递送途径的态度和偏好。
目的:由于给药途径可能影响对人类免疫缺陷病毒暴露前预防(PrEP)的兴趣,我们探讨了年轻跨性别男性和跨男性青年(TG)对目前可用和正在开发的PrEP给药方法的态度和偏好。方法:从美国中西部一家为青年服务的性别诊所招募了15名年龄在15-24岁的TG男性。参与者完成了理论指导的个人访谈,评估人口统计学、风险行为、对PrEP输送途径的态度和偏好,以及使用激素治疗阴道出血的经验。使用内容分析分析转录本。结果:平均年龄17.7岁(标准差1.4);12名白人,2名混血儿,1名黑人;13人有过性经历。口服避孕药的好处包括使用方便,无需计划性生活;障碍包括坚持治疗的挑战,吞咽药物的困难。注射益处包括长效、易于依从性;障碍包括注射分娩,臀注射不适。阴道环的好处包括使用方便,长效;障碍包括阴道物品的不适,性别焦虑的加剧。局部益处包括按需使用,易于使用;障碍包括不喜欢配方,使用阴道/直肠产品的不适。种植体的优点包括长效,易于使用;障碍包括放置程序,对破损/迁移的担忧。有注射、植入或宫内节育器出血管理经验的5名参与者中有4人报告首选PrEP植入。有过服用避孕药经历的9名参与者中有6人表示更倾向于服用PrEP药丸。讨论:通过临床医生引导和解决年轻TG男性确定的PrEP递送途径的障碍,PrEP的摄取可能会得到改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信